{"id":830404,"date":"2025-03-27T07:03:27","date_gmt":"2025-03-27T11:03:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\/"},"modified":"2025-03-27T07:03:27","modified_gmt":"2025-03-27T11:03:27","slug":"bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\/","title":{"rendered":"Bausch + Lomb Announces Voluntary Recall of enVista Aspire\u2122, enVista Envy\u2122 and Certain enVista\u00ae Monofocal Intraocular Lenses"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Bausch + Lomb Announces Voluntary Recall of enVista Aspire\u2122, enVista Envy\u2122 and Certain enVista<sup>\u00ae<\/sup> Monofocal Intraocular Lenses<\/b><\/p>\n<p>VAUGHAN, Ontario&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nBausch + Lomb Corporation (NYSE\/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced a voluntary recall of intraocular lenses (IOLs) on its enVista platform. This action was taken out of an abundance of caution after the company received reports of complications, the cause of which could not immediately be explained.\n<\/p>\n<p>\n\u201cAs much as we believe in the enVista platform, patient safety will always be our number one priority,\u201d said Brent Saunders, chairman and CEO, Bausch + Lomb. \u201cSurgeons and patients trust Bausch + Lomb, and I believe that this voluntary recall is the best thing we can do to honor that trust.\u201d\n<\/p>\n<p>\nThe recall is in response to an increased number of reports of toxic anterior segment syndrome (TASS) in conjunction with implantation of enVista Aspire, enVista Envy and certain enVista monofocal IOLs.\n<\/p>\n<p>\nTASS, a potential complication in any cataract surgery, is an inflammatory reaction inside the eye that can have a variety of causes. When it occurs, this complication typically appears 12 \u2013 48 hours after eye surgery. All enVista TASS cases reported to Bausch + Lomb responded quickly to treatment, and none have required removal of the lens.\n<\/p>\n<p>\n\u201cThese reports represent an extremely small percentage of implanted lenses, with a positive prognosis for everyone involved,\u201d Saunders continued. \u201cWe look forward to identifying a root cause and bringing the enVista platform back to market.\u201d\n<\/p>\n<p>\nCommunications to eye care professionals are underway, with information on impacted lots and return protocols. Click <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.bausch.com%252Fglobalassets%252Fpdf%252Fpr%252Fbrent-saunders-envista-customer-letter-final.pdf%26data%3D05%257C02%257CCaryn.Marshall%2540bausch.com%257C1c1999b611aa43764a6e08dd6ca02025%257C847856c8738e4dbe9d18a304f99de0e0%257C0%257C0%257C638786157179954970%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C0%257C%257C%257C%26sdata%3DYT9AwMThx7NKu%252FqW2NRt2ZW5jybaEH4cPIOsPpbgz4s%253D%26reserved%3D0&amp;esheet=54229509&amp;newsitemid=20250327583205&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=6286f458c10d881e6490cd5b0341ced2\">here<\/a> for a message from Saunders to customers, and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.bausch.com%252Fglobalassets%252Fpdf%252Fpr%252Fwhat-is-tass-final.pdf%26data%3D05%257C02%257CCaryn.Marshall%2540bausch.com%257C1c1999b611aa43764a6e08dd6ca02025%257C847856c8738e4dbe9d18a304f99de0e0%257C0%257C0%257C638786157179933956%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C0%257C%257C%257C%26sdata%3DZVun6OdmwJbqOaFUQ%252Br98pl8%252FDO%252BuK%252F4w2XufrWgRQw%253D%26reserved%3D0&amp;esheet=54229509&amp;newsitemid=20250327583205&amp;lan=en-US&amp;anchor=here&amp;index=2&amp;md5=41d27a069f6b27a1329fed2d95e31b28\">here<\/a> for a TASS fact sheet.\n<\/p>\n<p><b>About Bausch + Lomb<br \/>\n<br \/><\/b>Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world \u2013 from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttp%253A%252F%252Fwww.bausch.com%252F%26data%3D05%257C02%257CKristy.Marks%2540bausch.com%257Cfbdd2eee03a847254c7808dc2db200aa%257C847856c8738e4dbe9d18a304f99de0e0%257C0%257C0%257C638435489762975076%257CUnknown%257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%257C0%257C%257C%257C%26sdata%3DpPGiB1wqFvTfypm1vr987CFdLuMwxF8DcTDzrT0ao50%253D%26reserved%3D0&amp;esheet=54229509&amp;newsitemid=20250327583205&amp;lan=en-US&amp;anchor=www.bausch.com&amp;index=3&amp;md5=b03a1ead657b299d83a04358882f4fb5\">www.bausch.com<\/a> and connect with us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FBauschandLomb%2F&amp;esheet=54229509&amp;newsitemid=20250327583205&amp;lan=en-US&amp;anchor=Facebook&amp;index=4&amp;md5=69d04847fc8ea6b7366a4bdc523d20f8\">Facebook<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fbauschlomb%2F&amp;esheet=54229509&amp;newsitemid=20250327583205&amp;lan=en-US&amp;anchor=Instagram&amp;index=5&amp;md5=00fc9198596ed64526ccfae1395379d9\">Instagram<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fbausch-%26-lomb%2F&amp;esheet=54229509&amp;newsitemid=20250327583205&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=6&amp;md5=e2672fdabae421275e9f68882942e6dc\">LinkedIn<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FBauschLomb&amp;esheet=54229509&amp;newsitemid=20250327583205&amp;lan=en-US&amp;anchor=X&amp;index=7&amp;md5=fd1a1a9cba65374b22aad61d4497039b\">X<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fbauschlomb1&amp;esheet=54229509&amp;newsitemid=20250327583205&amp;lan=en-US&amp;anchor=YouTube&amp;index=8&amp;md5=d6c57fe74a19ca8a97085aa6552d3375\">YouTube<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250327583205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250327583205\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250327583205\/en\/<\/a><\/span><\/p>\n<p><b>Media Contact:<br \/>\n<\/b><br \/>Caryn Marshall<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:caryn.marshall@bausch.com\">caryn.marshall@bausch.com<br \/>\n<\/a><br \/>(908) 493-1381\n<\/p>\n<p><b>Investor Contact:<br \/>\n<\/b><br \/>George Gadkowski<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:george.gadkowski@bausch.com\">george.gadkowski@bausch.com<br \/>\n<\/a><br \/>(<span class=\"bwuline\">877) 354-3705 (toll free)<br \/>\n<\/span><br \/>(908) 927-0735\n<\/p>\n<p><b>KEYWORDS:<\/b> United States North America Canada<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Medical Supplies Health Medical Devices Surgery General Health Optical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250327583205\/en\/1668940\/3\/Bausch_Lomb_logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Bausch + Lomb Announces Voluntary Recall of enVista Aspire\u2122, enVista Envy\u2122 and Certain enVista\u00ae Monofocal Intraocular Lenses VAUGHAN, Ontario&#8211;(BUSINESS WIRE)&#8211; Bausch + Lomb Corporation (NYSE\/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced a voluntary recall of intraocular lenses (IOLs) on its enVista platform. This action was taken out of an abundance of caution after the company received reports of complications, the cause of which could not immediately be explained. \u201cAs much as we believe in the enVista platform, patient safety will always be our number one priority,\u201d said Brent Saunders, chairman and CEO, Bausch + Lomb. \u201cSurgeons and patients trust Bausch + Lomb, and I believe that this voluntary &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Bausch + Lomb Announces Voluntary Recall of enVista Aspire\u2122, enVista Envy\u2122 and Certain enVista\u00ae Monofocal Intraocular Lenses&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-830404","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bausch + Lomb Announces Voluntary Recall of enVista Aspire\u2122, enVista Envy\u2122 and Certain enVista\u00ae Monofocal Intraocular Lenses - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bausch + Lomb Announces Voluntary Recall of enVista Aspire\u2122, enVista Envy\u2122 and Certain enVista\u00ae Monofocal Intraocular Lenses - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Bausch + Lomb Announces Voluntary Recall of enVista Aspire\u2122, enVista Envy\u2122 and Certain enVista\u00ae Monofocal Intraocular Lenses VAUGHAN, Ontario&#8211;(BUSINESS WIRE)&#8211; Bausch + Lomb Corporation (NYSE\/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced a voluntary recall of intraocular lenses (IOLs) on its enVista platform. This action was taken out of an abundance of caution after the company received reports of complications, the cause of which could not immediately be explained. \u201cAs much as we believe in the enVista platform, patient safety will always be our number one priority,\u201d said Brent Saunders, chairman and CEO, Bausch + Lomb. \u201cSurgeons and patients trust Bausch + Lomb, and I believe that this voluntary &hellip; Continue reading &quot;Bausch + Lomb Announces Voluntary Recall of enVista Aspire\u2122, enVista Envy\u2122 and Certain enVista\u00ae Monofocal Intraocular Lenses&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-27T11:03:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250327583205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Bausch + Lomb Announces Voluntary Recall of enVista Aspire\u2122, enVista Envy\u2122 and Certain enVista\u00ae Monofocal Intraocular Lenses\",\"datePublished\":\"2025-03-27T11:03:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\\\/\"},\"wordCount\":461,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250327583205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\\\/\",\"name\":\"Bausch + Lomb Announces Voluntary Recall of enVista Aspire\u2122, enVista Envy\u2122 and Certain enVista\u00ae Monofocal Intraocular Lenses - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250327583205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-03-27T11:03:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250327583205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250327583205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bausch + Lomb Announces Voluntary Recall of enVista Aspire\u2122, enVista Envy\u2122 and Certain enVista\u00ae Monofocal Intraocular Lenses\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bausch + Lomb Announces Voluntary Recall of enVista Aspire\u2122, enVista Envy\u2122 and Certain enVista\u00ae Monofocal Intraocular Lenses - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\/","og_locale":"en_US","og_type":"article","og_title":"Bausch + Lomb Announces Voluntary Recall of enVista Aspire\u2122, enVista Envy\u2122 and Certain enVista\u00ae Monofocal Intraocular Lenses - Market Newsdesk","og_description":"Bausch + Lomb Announces Voluntary Recall of enVista Aspire\u2122, enVista Envy\u2122 and Certain enVista\u00ae Monofocal Intraocular Lenses VAUGHAN, Ontario&#8211;(BUSINESS WIRE)&#8211; Bausch + Lomb Corporation (NYSE\/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced a voluntary recall of intraocular lenses (IOLs) on its enVista platform. This action was taken out of an abundance of caution after the company received reports of complications, the cause of which could not immediately be explained. \u201cAs much as we believe in the enVista platform, patient safety will always be our number one priority,\u201d said Brent Saunders, chairman and CEO, Bausch + Lomb. \u201cSurgeons and patients trust Bausch + Lomb, and I believe that this voluntary &hellip; Continue reading \"Bausch + Lomb Announces Voluntary Recall of enVista Aspire\u2122, enVista Envy\u2122 and Certain enVista\u00ae Monofocal Intraocular Lenses\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-27T11:03:27+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250327583205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Bausch + Lomb Announces Voluntary Recall of enVista Aspire\u2122, enVista Envy\u2122 and Certain enVista\u00ae Monofocal Intraocular Lenses","datePublished":"2025-03-27T11:03:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\/"},"wordCount":461,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250327583205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\/","name":"Bausch + Lomb Announces Voluntary Recall of enVista Aspire\u2122, enVista Envy\u2122 and Certain enVista\u00ae Monofocal Intraocular Lenses - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250327583205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-03-27T11:03:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250327583205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250327583205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-announces-voluntary-recall-of-envista-aspire-envista-envy-and-certain-envista-monofocal-intraocular-lenses\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Bausch + Lomb Announces Voluntary Recall of enVista Aspire\u2122, enVista Envy\u2122 and Certain enVista\u00ae Monofocal Intraocular Lenses"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/830404","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=830404"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/830404\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=830404"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=830404"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=830404"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}